Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Cornea and External Disease > Does corneal tissue quality change with donor history of sleep apnea?
  • Cornea and External Disease

Does corneal tissue quality change with donor history of sleep apnea?

Kelsey Moroz

A donor’s history of sleep apnea is associated with a lower endothelial cell density (ECD) in corneal tissues, which could potentially impact the quality of the corneal tissue used for transplantation, according to a study.

Further research is needed to understand if and how this affects post-transplantation outcomes.

The study analyzed data from 50,170 corneal tissues donated by 25,399 individuals without sleep apnea and 5473 tissues from 2774 donors with a history of sleep apnea. Findings revealed that tissues from donors with sleep apnea exhibited lower ECD by an average of 51 cells/mm² compared to those from donors without sleep apnea (P < 0.001). Multivariate linear regression indicated that a history of sleep apnea predicted a reduction in ECD by 13.72 cells/mm² (P = 0.0264).

Secondary analysis highlighted that underweight and obese body mass indexes were significant predictors of increased ECD in donors without sleep apnea (P < 0.0001 and P = 0.025, respectively), while body mass index was not a significant predictor for those with sleep apnea. In a smaller subset of 10,756 tissues, sleep apnea did not significantly affect central corneal thickness.

The study concludes that a donor’s history of sleep apnea is associated with lower ECD, marking the first time this correlation has been identified in a large eye bank dataset.

Reference
Ramini A, Zhang N, Lee M, et al. The Impact of Donor History of Sleep Apnea on Corneal Tissue Evaluation Parameters. Cornea. 2024;doi: 10.1097/ICO.0000000000003588. Epub ahead of print. PMID: 38886882.

Share

Related Content

  • Cornea and External Disease

Quiz: The impact of blepharitis and conjunctivitis on quality of life

  • Cornea and External Disease

Phase 3 trial of cenegermin-bkbj for PCED enrolls first US patient

  • Cornea and External Disease

Cornea specialists identify key clinical signs linked to microbial keratitis subtypes

Cornea Update: Corneal Dystrophies & Related Conditions with an Update on Genetic Assessment and Treatment
  • Cornea and External Disease

Preventing complications of superficial keratectomy

  • Conference Roundup

Phase 1/2 CLARA study shows AURN001 improves BCVA compared with standard of care for corneal endothelial dysfunction

  • Conference Roundup

Epioxa crosslinking system has positive outcomes at 30 months in patients with keratoconus

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon